Femtocells are low-cost, miniature basestations intended to improve indoor coverage in 3G networks and beyond. One of the main issues in adopting femtocells en masse is the surge in interference to the mobile users served by the macrocell arising from unplanned networks and private access. Therefore, distributed power control mechanisms for femtocells are essential to shield the existing users of the macrocell as well as to enable scalable femtocell deployments. This paper studies several such power control schemes that strike an effective balance between the throughput of the femto users and the degradation in macrocell performance.
Orthogonal Frequency Division Multiple Access (OFDMA) is the preferred multiple access scheme for future broadband cellular systems as it provides high spectral efficiency. The choice of OFDMA scheduler and the amount of channel quality feedback from users together determine the achievable throughput and fairness. Channel quality reporting by all active users across the entire carrier bandwidth may result in significant uplink overhead. This paper discusses the performance of two possible OFDMA schedulers based on the class and channel condition weighted proportionally fair scheduler. The impact of different scheduler parameters are investigated. The paper then analyzes the performance of the top-M scheme, which is a candidate channel quality overhead reduction proposal being discussed in 3GPP Long Term Evolution. It is shown that the top-M scheme, with significantly lower uplink overhead, provides similar performance as the case where the network has complete channel quality information.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.